It directs Scl1 recognition and binding to the cellular fibronectin type III repeats, the extracellular domains A (EDA) and B (EDB) – also known as oncofetal fibronectin – deposited by cancer associated fibroblasts (CAFs) (39, 40, 45, 46). The gene discussed is FN1; the disease is cancer.